BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 8608131)

  • 1. Active site mutations define the pathway for the cooperative activation of cAMP-dependent protein kinase.
    Herberg FW; Taylor SS; Dostmann WR
    Biochemistry; 1996 Mar; 35(9):2934-42. PubMed ID: 8608131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent activation.
    Kim C; Cheng CY; Saldanha SA; Taylor SS
    Cell; 2007 Sep; 130(6):1032-43. PubMed ID: 17889648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-site mutations in cyclic AMP-sensitive revertants of a Ka mutant of S49 mouse lymphoma cells reduce the affinity of regulatory subunit of cyclic AMP-dependent protein kinase for catalytic subunit.
    Cauthron RD; Gorman KB; Symcox MM; Steinberg RA
    J Cell Physiol; 1995 Nov; 165(2):376-85. PubMed ID: 7593216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping intersubunit interactions of the regulatory subunit (RIalpha) in the type I holoenzyme of protein kinase A by amide hydrogen/deuterium exchange mass spectrometry (DXMS).
    Hamuro Y; Anand GS; Kim JS; Juliano C; Stranz DD; Taylor SS; Woods VL
    J Mol Biol; 2004 Jul; 340(5):1185-96. PubMed ID: 15236976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definition of an electrostatic relay switch critical for the cAMP-dependent activation of protein kinase A as revealed by the D170A mutant of RIalpha.
    Abu-Abed M; Das R; Wang L; Melacini G
    Proteins; 2007 Oct; 69(1):112-24. PubMed ID: 17596845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the dominance of mutations in cAMP-binding sites of murine type I cAMP-dependent protein kinase in activation of kinase from heterozygous mutant lymphoma cells.
    Shuntoh H; Steinberg RA
    J Cell Physiol; 1991 Jan; 146(1):86-93. PubMed ID: 1846638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic-AMP and pseudosubstrate effects on type-I A-kinase regulatory and catalytic subunit binding kinetics.
    Anand G; Taylor SS; Johnson DA
    Biochemistry; 2007 Aug; 46(32):9283-91. PubMed ID: 17658893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing cAMP-dependent protein kinase holoenzyme complexes I alpha and II beta by FT-IR and chemical protein footprinting.
    Yu S; Mei FC; Lee JC; Cheng X
    Biochemistry; 2004 Feb; 43(7):1908-20. PubMed ID: 14967031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant strategies for rapid purification of catalytic subunits of cAMP-dependent protein kinase.
    Hemmer W; McGlone M; Taylor SS
    Anal Biochem; 1997 Feb; 245(2):115-22. PubMed ID: 9056191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of activation of cAMP-dependent protein kinase: in Mucor rouxii the apparent specific activity of the cAMP-activated holoenzyme is different than that of its free catalytic subunit.
    Zaremberg V; Donella-Deana A; Moreno S
    Arch Biochem Biophys; 2000 Sep; 381(1):74-82. PubMed ID: 11019822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rearrangements in a hydrophobic core region mediate cAMP action in the regulatory subunit of PKA.
    Hahnefeld C; Moll D; Goette M; Herberg FW
    Biol Chem; 2005 Jul; 386(7):623-31. PubMed ID: 16207083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of the A-helix of the catalytic subunit of cAMP-dependent protein kinase for stability and for orienting subdomains at the cleft interface.
    Herberg FW; Zimmermann B; McGlone M; Taylor SS
    Protein Sci; 1997 Mar; 6(3):569-79. PubMed ID: 9070439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human regulatory subunit RI beta of cAMP-dependent protein kinases: expression, holoenzyme formation and microinjection into living cells.
    Solberg R; Taskén K; Wen W; Coghlan VM; Meinkoth JL; Scott JD; Jahnsen T; Taylor SS
    Exp Cell Res; 1994 Oct; 214(2):595-605. PubMed ID: 7925653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structures of RIalpha subunit of cyclic adenosine 5'-monophosphate (cAMP)-dependent protein kinase complexed with (Rp)-adenosine 3',5'-cyclic monophosphothioate and (Sp)-adenosine 3',5'-cyclic monophosphothioate, the phosphothioate analogues of cAMP.
    Wu J; Jones JM; Nguyen-Huu X; Ten Eyck LF; Taylor SS
    Biochemistry; 2004 Jun; 43(21):6620-9. PubMed ID: 15157095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Holoenzyme interaction sites in the cAMP-dependent protein kinase. Histidine 87 in the catalytic subunit complements serine 99 in the type I regulatory subunit.
    Cox S; Taylor SS
    J Biol Chem; 1994 Sep; 269(36):22614-22. PubMed ID: 8077212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cAMP-dependent protein kinase regulatory subunit type IIbeta: active site mutations define an isoform-specific network for allosteric signaling by cAMP.
    Zawadzki KM; Taylor SS
    J Biol Chem; 2004 Feb; 279(8):7029-36. PubMed ID: 14625280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalytic independent functions of a protein kinase as revealed by a kinase-dead mutant: study of the Lys72His mutant of cAMP-dependent kinase.
    Iyer GH; Garrod S; Woods VL; Taylor SS
    J Mol Biol; 2005 Sep; 351(5):1110-22. PubMed ID: 16054648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of substrate on type I and type II PKA holoenzyme dissociation.
    Vigil D; Blumenthal DK; Brown S; Taylor SS; Trewhella J
    Biochemistry; 2004 May; 43(19):5629-36. PubMed ID: 15134437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoform specific differences in binding of a dual-specificity A-kinase anchoring protein to type I and type II regulatory subunits of PKA.
    Burns LL; Canaves JM; Pennypacker JK; Blumenthal DK; Taylor SS
    Biochemistry; 2003 May; 42(19):5754-63. PubMed ID: 12741833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between domains in the regulatory subunit of cAMP-dependent protein kinase: influence of amino terminus on cAMP binding and holoenzyme formation.
    Herberg FW; Dostmann WR; Zorn M; Davis SJ; Taylor SS
    Biochemistry; 1994 Jun; 33(23):7485-94. PubMed ID: 8003514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.